77 related articles for article (PubMed ID: 15239142)
21. Gene expression profiles for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer.
Tsao DA; Chang HJ; Lin CY; Hsiung SK; Huang SE; Ho SY; Chang MS; Chiu HH; Chen YF; Cheng TL; Shiu-Ru L
DNA Cell Biol; 2010 Jun; 29(6):285-93. PubMed ID: 20482226
[TBL] [Abstract][Full Text] [Related]
22. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
[TBL] [Abstract][Full Text] [Related]
23. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
[TBL] [Abstract][Full Text] [Related]
24. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
25. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
26. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Fakhrejahani E; Miyamoto A; Tanigawa N
Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
[TBL] [Abstract][Full Text] [Related]
27. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
28. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling.
Schmidt WM; Kalipciyan M; Dornstauder E; Rizovski B; Steger GG; Sedivy R; Mueller MW; Mader RM
Int J Cancer; 2004 Nov; 112(2):200-12. PubMed ID: 15352031
[TBL] [Abstract][Full Text] [Related]
29. 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
Inada T; Ogata Y; Kubota T; Tomikawa M; Yamamoto S; Andoh J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2000; 20(4):2457-62. PubMed ID: 10953310
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
[TBL] [Abstract][Full Text] [Related]
31. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR.
Sakakura C; Takemura M; Hagiwara A; Shimomura K; Miyagawa K; Nakashima S; Yoshikawa T; Takagi T; Kin S; Nakase Y; Fujiyama J; Hayasizaki Y; Okazaki Y; Yamagishi H
Br J Cancer; 2004 Feb; 90(3):665-71. PubMed ID: 14760382
[TBL] [Abstract][Full Text] [Related]
33. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways.
Lv XG; Ji MY; Dong WG; Lei XF; Liu M; Guo XF; Wang J; Fang C
Mol Med Rep; 2012 May; 5(5):1220-6. PubMed ID: 22366766
[TBL] [Abstract][Full Text] [Related]
34. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
[TBL] [Abstract][Full Text] [Related]
35. [Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression].
Geng M; Yin YC; Cao YC; Fu ZJ; Tai YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):276-9. PubMed ID: 18478476
[TBL] [Abstract][Full Text] [Related]
36. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
[TBL] [Abstract][Full Text] [Related]
37. Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer.
Hosaka N; Ichikawa Y; Ishikawa T; Nagashima Y; Kunisaki C; Takahashi M; Moriwaki Y; Akiyama H; Yamaguchi S; Ota M; Ooki S; Ike H; Shimada H
Anticancer Res; 2001; 21(1A):229-35. PubMed ID: 11299739
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
39. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
[TBL] [Abstract][Full Text] [Related]
40. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
